Related Experiment Videos
Etomidate and midazolam for procedural sedation: prospective, randomized trial.
Gregory S Hunt1, Matthew T Spencer, Daniel P Hays
1Department of Emergency Medicine, St. Luke's Hospital, New Bedford, MA 02740, USA.
The American Journal of Emergency Medicine
|May 26, 2005
Summary
Etomidate significantly reduces procedural sedation recovery time compared to midazolam, without affecting patient disposition time or sedation quality. This finding supports etomidate as an effective alternative for procedural sedation.
Area of Science:
- Emergency Medicine
- Pharmacology
Background:
- Procedural sedation is crucial in emergency settings.
- Midazolam is a commonly used sedative, but its recovery profile can be lengthy.
Purpose of the Study:
- To compare the efficacy of etomidate versus midazolam for procedural sedation.
- To evaluate differences in sedation time and patient disposition time.
Main Methods:
- A prospective, randomized, double-blind trial was conducted.
- Etomidate (0.10 mg/kg) and midazolam (0.035 mg/kg) were administered for procedural sedation.
- Patients undergoing reduction of joint dislocations or long bone fractures were included.
Main Results:
- Forty-five patients were enrolled; 24 received etomidate and 21 received midazolam.
- Mean sedation time was significantly shorter with etomidate (15 min) compared to midazolam (32 min) (P<.001).
- Time to patient disposition and sedation quality were similar between the two groups.
Conclusions:
- Etomidate offers a significant reduction in recovery time compared to midazolam for procedural sedation.
- The quality of sedation and time to patient disposition remain comparable.
- Etomidate presents a valuable alternative for procedural sedation, potentially improving patient throughput.